These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 23030476)

  • 1. Outcomes of patients with chronic heart failure and iron deficiency treated with intravenous iron: a meta-analysis.
    Kapoor M; Schleinitz MD; Gemignani A; Wu WC
    Cardiovasc Hematol Disord Drug Targets; 2013 Mar; 13(1):35-44. PubMed ID: 23030476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of iron therapy in patients with chronic heart failure and iron deficiency: a systematic review and meta-analysis based on 15 randomised controlled trials.
    Zhang J; Hu S; Jiang Y; Zhou Y
    Postgrad Med J; 2020 Dec; 96(1142):766-776. PubMed ID: 32843482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.
    Silverberg DS; Wexler D; Blum M; Keren G; Sheps D; Leibovitch E; Brosh D; Laniado S; Schwartz D; Yachnin T; Shapira I; Gavish D; Baruch R; Koifman B; Kaplan C; Steinbruch S; Iaina A
    J Am Coll Cardiol; 2000 Jun; 35(7):1737-44. PubMed ID: 10841219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency.
    Usmanov RI; Zueva EB; Silverberg DS; Shaked M
    J Nephrol; 2008; 21(2):236-42. PubMed ID: 18446719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferric carboxymaltose in patients with heart failure and iron deficiency.
    Anker SD; Comin Colet J; Filippatos G; Willenheimer R; Dickstein K; Drexler H; Lüscher TF; Bart B; Banasiak W; Niegowska J; Kirwan BA; Mori C; von Eisenhart Rothe B; Pocock SJ; Poole-Wilson PA; Ponikowski P;
    N Engl J Med; 2009 Dec; 361(25):2436-48. PubMed ID: 19920054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis.
    Avni T; Leibovici L; Gafter-Gvili A
    Eur J Heart Fail; 2012 Apr; 14(4):423-9. PubMed ID: 22348897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous Iron Therapy in Heart Failure.
    Altman NL; Patel A
    Heart Fail Clin; 2018 Oct; 14(4):537-543. PubMed ID: 30266362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study.
    Silverberg DS; Wexler D; Sheps D; Blum M; Keren G; Baruch R; Schwartz D; Yachnin T; Steinbruch S; Shapira I; Laniado S; Iaina A
    J Am Coll Cardiol; 2001 Jun; 37(7):1775-80. PubMed ID: 11401110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron substitution in the treatment of chronic heart failure.
    Gstrein C; Meyer M; Anabitarte P
    Swiss Med Wkly; 2017; 147():w14453. PubMed ID: 28695549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
    Okonko DO; Grzeslo A; Witkowski T; Mandal AK; Slater RM; Roughton M; Foldes G; Thum T; Majda J; Banasiak W; Missouris CG; Poole-Wilson PA; Anker SD; Ponikowski P
    J Am Coll Cardiol; 2008 Jan; 51(2):103-12. PubMed ID: 18191732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of iron deficiency in chronic heart failure].
    Uskach TM
    Ter Arkh; 2022 May; 94(4):572-578. PubMed ID: 36286810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous iron for acute and chronic heart failure with reduced ejection fraction (HFrEF) patients with iron deficiency: An updated systematic review and meta-analysis.
    Awad AK; Abdelgalil MS; Gonnah AR; Mouffokes A; Ahmad U; Awad AK; Elbadawy MA; Roberts DH
    Clin Med (Lond); 2024 May; 24(3):100211. PubMed ID: 38643833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of the treatment of iron deficiency on clinical condition, left ventricular function, and quality of life in patients with chronic heart failure.
    Mirdamadi A; Arefeh A; Garakyaraghi M; Pourmoghadas A
    Acta Biomed; 2018 Jun; 89(2):214-218. PubMed ID: 29957754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ivabradine Improves Cardiac Function and Increases Exercise Capacity in Patients with Chronic Heart Failure.
    Pei H; Miao W; Xie WZ; Wang W; Zhao D; Su GH; Zhao Z
    Int Heart J; 2019 Jul; 60(4):899-909. PubMed ID: 31308326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous Iron Therapy in Heart Failure With Reduced Ejection Fraction: Tackling the Deficiency.
    Sawicki KT; Ardehali H
    Circulation; 2021 Jul; 144(4):253-255. PubMed ID: 34310166
    [No Abstract]   [Full Text] [Related]  

  • 17. The Efficacy and Safety of Iron Supplementation in Patients With Heart Failure and Iron Deficiency: A Systematic Review and Meta-analysis.
    Qian C; Wei B; Ding J; Wu H; Wang Y
    Can J Cardiol; 2016 Feb; 32(2):151-9. PubMed ID: 26454467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study.
    González-Costello J; Comín-Colet J; Lupón J; Enjuanes C; de Antonio M; Fuentes L; Moliner-Borja P; Farré N; Zamora E; Manito N; Pujol R; Bayés-Genis A
    BMC Cardiovasc Disord; 2018 Nov; 18(1):206. PubMed ID: 30382817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious complications and mortality associated with the use of IV iron therapy: a systematic review and meta-analysis.
    Salim SA; Cheungpasitporn W; Elmaraezy A; Jawafi O; Rahman M; Aeddula NR; Tirupathi R; Fülöp T
    Int Urol Nephrol; 2019 Oct; 51(10):1855-1865. PubMed ID: 31485910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an accelerated intravenous iron regimen in hospitalized patients with advanced heart failure and iron deficiency.
    Reed BN; Blair EA; Thudium EM; Waters SB; Sueta CA; Jensen BC; Rodgers JE
    Pharmacotherapy; 2015 Jan; 35(1):64-71. PubMed ID: 25556867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.